Eiki Hanada Selected Research

Eiki Hanada Research Topics

5	Neoplasms (Cancer) 01/2022 - 02/2005
5	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2005
3	Carcinoma (Carcinomatosis) 01/2022 - 05/2015
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 09/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 04/2019
1	Hyperaldosteronism (Conn Syndrome) 06/2018
1	Cushing Syndrome 06/2018
1	Convalescence 05/2018
1	Adenocarcinoma 05/2015
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 03/2015
1	Transitional Cell Carcinoma 02/2005
1	Pelvic Neoplasms 02/2005

2	Docetaxel (Taxotere)FDA Link 09/2019 - 05/2015
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2022
1	Pharmaceutical PreparationsIBA 09/2019
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 04/2019
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	ProteomeIBA 07/2015
1	Prostate-Specific Antigen (Semenogelase)IBA 05/2015
1	AndrogensIBA 05/2015
1	gamma-GlutamylcyclotransferaseIBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	Methotrexate (Mexate)FDA LinkGeneric 02/2005
1	Gemcitabine FDA Link 02/2005
1	Etoposide (VP 16)FDA LinkGeneric 02/2005
1	Vinblastine (Vinblastine Sulfate)FDA Link 02/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2005
1	Cisplatin (Platino)FDA LinkGeneric 02/2005

3	Drug Therapy (Chemotherapy) 05/2015 - 02/2005
2	Radiotherapy 10/2006 - 02/2005
1	Nephrectomy 01/2022
1	Adrenalectomy 06/2018
1	Prostatectomy (Retropubic Prostatectomy) 05/2018
1	Combined Modality Therapy 03/2015
1	Nephroureterectomy 02/2005
1	Combination Drug Therapy (Combination Chemotherapy) 02/2005
1	Adjuvant Chemotherapy 02/2005